v3.26.1
Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders - Additional Information (Details) - shares
shares in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Earnings Per Share [Abstract]    
Antidilutive securities 25.7 26.9